NeueHealth Inc (NEUE)
6.050
-0.37
(-5.76%)
USD |
NYSE |
May 09, 16:00
6.05
0.00 (0.00%)
After-Hours: 20:00
NeueHealth Cash from Financing (TTM): 49.91M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 49.91M |
September 30, 2023 | 211.66M |
June 30, 2023 | 470.16M |
March 31, 2023 | 471.83M |
December 31, 2022 | 1.066B |
September 30, 2022 | 1.052B |
June 30, 2022 | 745.88M |
Date | Value |
---|---|
March 31, 2022 | 1.436B |
December 31, 2021 | 1.044B |
September 30, 2021 | 912.56M |
June 30, 2021 | 1.390B |
March 31, 2021 | 912.66M |
December 31, 2020 | 712.44M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
49.91M
Minimum
Dec 2023
1.436B
Maximum
Mar 2022
805.76M
Average
912.56M
Median
Sep 2021
Cash from Financing (TTM) Benchmarks
Clover Health Investments Corp | -33.86M |
Oscar Health Inc | 33.25M |
Alignment Healthcare Inc | -0.26M |
The Cigna Group | -6.786B |
Centene Corp | -1.452B |